Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rubella in Denmark.

S Glismann1

  • 1Statens Serum Institut, Copenhagen, Denmark.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|June 12, 2004
PubMed
Summary
This summary is machine-generated.

Denmark

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rubella in Denmark.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Same author

High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2012
Same author

Burden and characteristics of influenza A and B in Danish intensive care units during the 2009/10 and 2010/11 influenza seasons.

Epidemiology and infection·2012
Same author

Electronic real-time surveillance for influenza-like illness: experience from the 2009 influenza A(H1N1) pandemic in Denmark.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2011
Same author

Nosocomial measles cluster in Denmark following an imported case, December 2008-January 2009.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2009
Same author

Measles is still a cause for concern in Europe.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2008
Same journal

Author's correction for Euro Surveill. 2026;31(24).

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Dermatophilosis among men who have sex with men, Stockholm, Sweden, March to June, 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Population-based prevalence and screening gaps of hepatitis C, B and D, Germany, 2020 to 2021.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Ongoing multi-country outbreak of carbapenem-resistant <i>Enterobacter hormaechei</i> ST1344 carrying <i>bla</i> <sub>NDM-5</sub> in the European Union/European Economic Area, March 2025 to April 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Detection of antibodies against avian influenza in European dairy cattle, the Netherlands, January 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

First steps in establishing surveillance of bloodstream infections from electronic health record derived data, EU/EEA countries, March 2023 to March 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
See all related articles

Area of Science:

  • Epidemiology
  • Public Health
  • Vaccinology

Background:

  • Rubella incidence in Denmark averaged 20,000 cases annually until 1987.
  • Reported cases dramatically decreased to 1006 in 1989, with current incidence <1 per 100,000 population.

Purpose of the Study:

  • To assess the impact of rubella vaccination programs in Denmark.
  • To evaluate the sustainability of low rubella incidence and consider future control measures.

Main Methods:

  • Analysis of historical rubella case data in Denmark.
  • Review of vaccination policies and introduction of the MMR vaccine.
  • Examination of notifiable disease status for congenital rubella syndrome and rubella in pregnancy.

Main Results:

Related Experiment Videos

  • Rubella vaccination of women of childbearing age (initiated 1980) and children (refunded from 1982) led to a significant incidence decrease.
  • Introduction of the Measles, Mumps, and Rubella (MMR) vaccine in 1987 further contributed to sustained low incidence.
  • Congenital rubella syndrome and rubella in pregnancy became notifiable diseases in 1994.

Conclusions:

  • Denmark's vaccination strategies have been highly successful in reducing rubella incidence.
  • Consideration of mandatory reporting for laboratory-diagnosed rubella cases is underway to meet WHO control goals.